Abou Kir Fertilizers (ABUK)
Egyptian Exchange · Egypt · prices in EGP · close of 22 Oct 2026
Key indicators
| Last close | EGP 92.90 |
|---|---|
| 52-week range | 45.18 – 96.29 |
| Return, 1 month / 3 months | −0.9% / +28.5% |
| Return, 1 year / 3 years | +91.3% / +47.4% |
| Trend | Uptrend |
| RSI (14) | 57 |
| Volatility (1 year) | 40.8% |
| Worst drawdown (1 year) | -26.9% |
| Average daily value traded | 123.02M EGP |
| Dividend yield | 8.9% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Abou Kir Fertilizers is an Egyptian producer of nitrogen fertilizers based in the Abu Qir area near Alexandria. The company makes ammonia and urea, which are sold as crop nutrients to agricultural customers, and it also supplies industrial buyers and export markets. Its plants sit close to the Mediterranean coast, which supports shipping of its products abroad. The business serves farmers and distributors who rely on nitrogen fertilizer for crop production.
The shares are listed on the Egyptian Exchange in Egypt under the code ABUK, and the price on this page is in Egyptian pounds (EGP). Our dividend records, which start in 2019, show payments in 8 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Abou Kir Fertilizers (ABUK) trades on the Egyptian Exchange in Egypt. It last closed at EGP 92.90 on 22 October 2026.
Its price-based Market X-Ray is 74 out of 100 (a strong price profile), ranking 22 of 276 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 91.3% and over the last three months it rose 28.5%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Egyptian Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 74 · Strong | Trading above its long-term averages and near its highs. | |
| Above 200-day average | 22.0% | ||
| From 52-week high | -3.0% | ||
| Momentum | 73 · Strong | Rising faster than most stocks on this exchange. | |
| 3-month return | 28.5% | ||
| 6-month return | 6.8% | ||
| 12-month return, skipping the last month | 93.0% | ||
| Stability (higher is calmer) | 61 · Fair | Typical risk for this exchange. | |
| Volatility, 1 year (lower is calmer) | 40.8% | ||
| Worst drawdown, 1 year (smaller is calmer) | -26.9% | ||
| Liquidity | 91 · Strong | Trades actively. | |
| Average daily value traded | 123.02M EGP | ||
| Zero-volume days | 0.0% | ||
| Income | 81 · Strong | Dividend is high and has been paid regularly. | |
| Dividend yield | 8.9% | ||
| Years with dividends | 5 |
Strengths
- Trend: Trading above its long-term averages and near its highs.
- Momentum: Rising faster than most stocks on this exchange.
- Liquidity: Trades actively.
- Income: Dividend is high and has been paid regularly.
Weak spots
No lens is weak against its exchange.
Returns
| 1 week | +6.0% |
|---|---|
| 1 month | −0.9% |
| 3 months | +28.5% |
| 6 months | +6.8% |
| 1 year | +91.3% |
| 3 years | +47.4% |
| 5 years | +589.6% |
Signals
| 50-day / 200-day average | 86.48 / 76.17 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | Yes |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 3.83 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 20 Apr 2026 | EGP 2.3000 |
| 22 Oct 2025 | EGP 6.0000 |
| 22 Oct 2024 | EGP 7.5000 |
| 24 Oct 2023 | EGP 3.0000 |
| 18 Oct 2022 | EGP 1.0000 |
| 10 May 2022 | EGP 1.0000 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Egyptian Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.